研究開発費、投資有価証券売却損、負債の部合計
- 【期間】
| 年度 | 研究開発費 | 投資有価証券売却損 | 負債の部合計 |
|---|
| 2008/03 | 31百万 | | - | | 2.37億 | |
| 2009/03 | - | | - | | 5.11億 | +115.1% |
| 2010/03 | - | | - | | 5.68億 | +11.2% |
| 2011/03 | - | | - | | 11.4億 | +101.4% |
| 2012/03 | - | | - | | 22.3億 | +94.8% |
| 2013/03 | 24百万 | -23.2% | - | | 15.6億 | -29.9% |
| 2014/03 | 123百万 | +410.4% | - | | 13.6億 | -13.2% |
| 2015/03 | 89百万 | -27.2% | - | | 24.2億 | +78.6% |
| 2016/03 | 92百万 | +2.4% | - | | 82.6億 | +241.3% |
| 2017/03 | 84百万 | -8.6% | 2.4百万 | | 111億 | +34.8% |
| 2018/03 | 119百万 | +42.4% | - | | 102億 | -8.2% |
| 2019/03 | 62百万 | -47.7% | - | | 88.2億 | -13.7% |
| 2020/03 | 75百万 | +19.6% | - | | 71.5億 | -18.9% |
| 2021/03 | 154百万 | +106.6% | - | | 73億 | +2.1% |
| 2022/03 | 177百万 | +14.9% | - | | 53.8億 | -26.2% |
| 2023/03 | 206百万 | +16.2% | - | | 41億 | -23.9% |
